AIOSYN

aiosyn-logo

Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer and CKD drug development studies for biopharma.

#SimilarOrganizations #People #Financial #Website #More

AIOSYN

Social Links:

Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Machine Learning Medical Device Pharmaceutical

Founded:
2021-07-30

Address:
Nijmegen, Gelderland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.aiosyn.org

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
3.3 M EUR

Technology used in webpage:
Domain Not Resolving Google Analytics Nginx Person Schema Gravatar Profiles BootstrapCDN Varnish Styled Components Statsig


Similar Organizations

perabiom-logo

Perabiom

Artificial intelligence, Biotechnology, Medical diagnostics, Medical devices

reti-health-logo

Reti Health

Preventing heart attacks and strokes with cardiovascular health screening from retinal images

socmedica-logo

Socmedica

artificial intelligence (AI) capable of predicting risks in the of field of medicine, biology, and pharmacology with clinical experience.

Current Employees Featured

not_available_image

Wouter Bulten
Wouter Bulten Co-founder and Chief Innovation Officer @ Aiosyn
Co-founder and Chief Innovation Officer
2021-08-01

david-tellez_image

David Tellez
David Tellez Co-founder and Chief Technology Officer @ Aiosyn
Co-founder and Chief Technology Officer
2021-07-01

Founder


david-tellez_image

David Tellez

not_available_image

Jeroen van der Laak

not_available_image

Patrick de Boer

not_available_image

Wouter Bulten

Investors List

health-innovations_image

Health Innovations

Health Innovations investment in Seed Round - Aiosyn

lumo-labs_image

LUMO labs

LUMO labs investment in Seed Round - Aiosyn

oostnl_image

OostNL

OostNL investment in Seed Round - Aiosyn

lumo-labs_image

LUMO labs

LUMO labs investment in Pre Seed Round - Aiosyn

oostnl_image

OostNL

OostNL investment in Pre Seed Round - Aiosyn

Official Site Inspections

http://www.aiosyn.org Semrush global rank: 13.97 M Semrush visits lastest month: 87

Unable to get host informations!!!

Loading ...

More informations about "Aiosyn"

Aiosyn Homepage - Aiosyn

Aiosynโ€™s NephroPath platform uses deep learning to analyze kidney structures and quantify lesions that impact kidney health. Co-developed with kidney pathology experts, the platform is โ€ฆSee details»

Aiosyn - Crunchbase Company Profile & Funding

Organization. Aiosyn . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Aiosyn uses artificial intelligence to develop โ€ฆSee details»

About - Aiosyn

Aiosyn was founded as a spin-off from the Computational Pathology research group of Radboud University Medical Center, one of the front-runners in the field. We build upon 20+ years of โ€ฆSee details»

Team - Aiosyn

Latest News: Aiosyn launches AiosynQC Pulse for external digital slide quality assessments, providing pathology labs with insights for slide quality improvement Learn more. Solutions for. โ€ฆSee details»

Aiosyn Company Profile 2024: Valuation, Funding & Investors

Aiosyn General Information Description. Developer of a medical analysis platform designed to accelerate the adoption of artificial intelligence in pathology diagnostics. The company's โ€ฆSee details»

About Aiosyn - Radboudumc

Aiosyn is awarded the NWO Take Off Phase II grant 23 December 2021 Aiosyn, a Radboudumc spin-off company that develops AI-powered pathology algorithms for clinical diagnostics and โ€ฆSee details»

Aiosyn - Pathology News

Aiosyn provides solutions for clinical diagnostics that address workflow inefficiencies by streamlining the pathological examination process, enhancing overall quality, and reducing โ€ฆSee details»

Aiosyn - Products, Competitors, Financials, Employees, โ€ฆ

About Aiosyn. Aiosyn is a healthtech company focused on developing precision pathology software solutions for the healthcare sector. The company offers AI-powered algorithms that โ€ฆSee details»

Aiosyn - GitHub

Aiosyn is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. - Aiosyn. ... This organization has no โ€ฆSee details»

Aiosyn, Radboudumc, and Pathologie-DNA are โ€ฆ

Nijmegen, Netherlands โ€“ Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to โ€ฆSee details»

Aiosyn announces the formation of a Scientific โ€ฆ

Oct 12, 2023 Nijmegen, The Netherlands โ€“ Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the formation of its Scientific Advisory Board. The โ€ฆSee details»

Aiosyn raises EUR 2 million to develop AI-powered algorithms - To ...

Dec 21, 2022 Aiosynโ€™s algorithms will work in close synergy with pathologists to address the growing workload and the demand to further improve diagnostic precision. AI helps with better โ€ฆSee details»

Aiosyn And Physiogenex Partner To Enhance Kidney Disease Drug ...

Mar 14, 2024 Nijmegen, The Netherlands โ€“ Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced โ€ฆSee details»

Dutch startup Aiosyn raises โ‚ฌ2 million to harness the power of AI โ€ฆ

Dec 22, 2022 The tremendous development Aiosyn has made in the last year solidifies this belief, and for this reason, the company has the support of Oost NL.โ€ AI for Pathology โ€ฆSee details»

Aiosyn: The benefits of AI implementation in mitotic figure counting

Apr 12, 2024 From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various โ€ฆSee details»

Aiosynโ€™s AI-powered Mitosis Detection Solution is Now Accessible โ€ฆ

May 2, 2024 Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the integration of its โ€ฆSee details»

Aiosyn Launches AiosynQC Pulse for External Digital Slide Quality ...

Nov 29, 2024 Aiosynโ€™s digital slide quality assessments use AI-powered artifact detection to deliver actionable key performance indicators (KPIs), helping labs improve pre-analytical โ€ฆSee details»

New start-up Aiosyn will bring AI research into pathology โ€ฆ

Sep 21, 2021 Aiosynโ€™s management team consists of Patrick de Boer, Jeroen van der Laak, David Tellez and Wouter Bulten. Katrien Grünberg, Geert Litjens and Francesco Ciompi are โ€ฆSee details»

Aiosyn leverages AI to get faster cancer diagnoses - IO

Mar 2, 2022 The Nijmegen start-up Aiosyn, a spin-off of the Radboudumc in The Netherlands, is developing an AI platform that helps pathologists reach diagnoses faster and more โ€ฆSee details»

Aiosyn Introduces Kidney AI Platform To Revolutionize Renal โ€ฆ

Sep 19, 2023 Healthy and sclerotic glomeruli in a renal biopsy are identified with Aiosynโ€™s solutions powered by AI Nijmegen, Netherlands โ€“ Aiosyn, a medical software company โ€ฆSee details»

linkstock.net © 2022. All rights reserved